Entecavir in clinical practice

Entecavir in clinical practice

Entecavir in clinical practice.

Saved in:

Bibliographic Details
Main Author:	Editorial Article
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:	Трансплантология (Москва)
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/326
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B
by: Hideo Takayama, et al.
Published: (2021-01-01)

Entecavir: stability and drug-excipient compatibility
by: Ariadne Botto Fiorot, et al.
Published: (2025-01-01)

Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients
by: Jinman Shao, et al.
Published: (2021-01-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Low-Content Quantitation in Entecavir Tablets Using 1064 nm Raman Spectroscopy
by: Yanlei Kang, et al.
Published: (2020-01-01)

Hepatoprotective and anti-inflammatory effects of entecavir or probiotics on Oxaliplatin-Induced Liver Injury in the rats.
by: Asem A. Askandar, et al.
Published: (2023-09-01)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016-07-01)

Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice
by: Yan Liu, et al.
Published: (2019-01-01)

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
by: Takuya Matsubara, et al.
Published: (2025-01-01)

Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”
by: Long-Shan Ji, et al.
Published: (2022-01-01)

HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01)

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
by: Shi-Jia Liu, et al.
Published: (2025-02-01)

Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis.
by: Weixia Ke, et al.
Published: (2014-01-01)

Comparative efficacy and safety of pegylated interferon-alpha monotherapy vs combination therapies with entecavir or tenofovir in chronic hepatitis B patients
by: Huiqing Liang, et al.
Published: (2025-05-01)

Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium <i>Microcystis novacekii</i>
by: Cléssius Ribeiro de Souza, et al.
Published: (2024-12-01)

Nicorandil in clinical cardiology practice
by: article Editorial
Published: (2012-02-01)

Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.
by: Ming Shi, et al.
Published: (2015-01-01)

Need of Treatment Modification During Entecavir Therapy in Patients with Chronic Hepatitis B: Long-Term Follow-Up Results for 120 Months
by: Hae Rim Kim, et al.
Published: (2025-01-01)

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
by: Liang Wang, et al.
Published: (2025-07-01)

SYMPOSIUM ”THE DIGITAL ERA OF ORPHAN DISEASE DIAGNOSIS IN PEDIATRICIAN'S PRACTICE: CLINICAL EXAMPLES FROM PRACTICE”
by: article Editorial
Published: (2025-05-01)

Effect of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamideantiviral Therapy on Renal Function in Chronic Hepatitis B Patients: A Real-World Retrospective Study
by: Li Y, et al.
Published: (2025-02-01)

Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy.
by: Yi Lin, et al.
Published: (2025-01-01)

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
by: article Editorial
Published: (2022-08-01)

Results of the Expert Forum on the application of perampanel in routine clinical practice
by: article Editorial
Published: (2020-09-01)

Effective implementation in practice the results of epidemiological, pharmacometrics and clinical studies
by: Editorial Article
Published: (2020-04-01)

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis
by: Yong Wang, et al.
Published: (2025-05-01)

Resolution of the Expert Forum on the use of perampanel in routine clinical practice in Russia
by: article Editorial
Published: (2018-11-01)

II academic school «Photodynamic therapy and photodiagnosis: fundamentals of use in clinical practice»
by: article Editorial
Published: (2015-03-01)

Results of the expert forum on the use of perampanel in adolescents with epilepsy in everyday clinical practice
by: article Editorial
Published: (2021-02-01)

Erratum to: «Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)»
by: article editorial
Published: (2025-03-01)

CLINICAL PRACTICE GUIDELINE: MANAGEMENT OF SINUSITIS (SUBJECT REVIEW OF AMERICAN ACADEMY OF PEDIATRICS)
by: article editorial
Published: (2006-08-01)

Resolution of the expert council on the topic “Clinical practice of drug therapy of thyroid cancer”
by: article Editorial
Published: (2022-08-01)

Real clinical practice data: comparison of the efficacy and safety of apixaban and rivaroxaban in the treatment of VTE
by: article Editorial
Published: (2022-05-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

On the ScientificandPractical Conference «Problems and Prospects of Anesthesiology and Critical Care Medicine and Clinical Toxicology» (in Rus)
by: editorial article
Published: (2016-10-01)

2016 EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE. THE SIXTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (CONSTITUTED BY REPRESENTATIVES OF 10 SOCIETIES AND BY INVITED EXPERTS)
by: Editorial article
Published: (2017-07-01)